Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
RSC Medicinal Chemistry
|
June 24, 2024
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA
Eric Sparkes, Jack W Markham, Rochelle Boyd, et al.
ACS Chemical Neuroscience
|
December 19, 2022
Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA
Liesl K Janssens, Adam Ametovski, Eric Sparkes, et al.
Addiction (Abingdon, England)
|
November 27, 2019
The Psychoactive Surveillance Consortium and Analysis Network (PSCAN): the first year
Andrew A Monte, Andrew Hopkinson, Jessica Saben, et al.
Drug Testing and Analysis
|
August 29, 2018
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA
Samuel D Banister, Axel Adams, Richard C Kevin, et al.
ACS Chemical Neuroscience
|
April 11, 2022
Defining Steric Requirements at CB<sub>1</sub> and CB<sub>2</sub> Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues
Jack Markham, Eric Sparkes, Rochelle Boyd, et al.
Theranostics
|
July 30, 2020
Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissue
François-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Theranostics
|
August 1, 2022
Erratum: Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissue: Erratum
François-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Frontiers in Physiology
|
April 21, 2023
MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
Thomas Harman, Michael Udoh, Dan L McElroy, et al.
RSC Medicinal Chemistry
|
March 21, 2022
Structure-activity relationships of valine, <i>tert</i>-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
Eric Sparkes, Elizabeth A Cairns, Richard C Kevin, et al.
ACS Chemical Neuroscience
|
October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
RSC Medicinal Chemistry
|
June 24, 2024
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA
Eric Sparkes, Jack W Markham, Rochelle Boyd, et al.
ACS Chemical Neuroscience
|
December 19, 2022
Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA
Liesl K Janssens, Adam Ametovski, Eric Sparkes, et al.
Addiction (Abingdon, England)
|
November 27, 2019
The Psychoactive Surveillance Consortium and Analysis Network (PSCAN): the first year
Andrew A Monte, Andrew Hopkinson, Jessica Saben, et al.
Drug Testing and Analysis
|
August 29, 2018
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA
Samuel D Banister, Axel Adams, Richard C Kevin, et al.
ACS Chemical Neuroscience
|
April 11, 2022
Defining Steric Requirements at CB<sub>1</sub> and CB<sub>2</sub> Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues
Jack Markham, Eric Sparkes, Rochelle Boyd, et al.
Theranostics
|
July 30, 2020
Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissue
François-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Theranostics
|
August 1, 2022
Erratum: Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissue: Erratum
François-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Frontiers in Physiology
|
April 21, 2023
MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
Thomas Harman, Michael Udoh, Dan L McElroy, et al.
RSC Medicinal Chemistry
|
March 21, 2022
Structure-activity relationships of valine, <i>tert</i>-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
Eric Sparkes, Elizabeth A Cairns, Richard C Kevin, et al.
ACS Chemical Neuroscience
|
October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Page
of 9